Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in India
NCT03548337Phase 4Completed
- Sponsor
- Pfizer
- Start
- May 2018
- Primary completion
- Dec 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Prevnar 13 in pneumococcal infection, sponsored by Pfizer. Started May 2018; status: completed.
02
Drugs
Prevnar 13
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT03548337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03548337.